Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp EBITDA Coverage Ratio 1 year YoY Change (%) for the year ending September 30, 2023: -72.80%

Embecta Corp EBITDA Coverage Ratio 1 year YoY Change (%) is -72.80% for the year ending September 30, 2023, a 23.51% change year over year. The EBITDA Coverage Ratio measures a company's ability to cover its interest expenses with its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). It indicates the company's capacity to meet interest obligations from its operational earnings. A higher ratio suggests better coverage and financial stability, indicating that the company generates sufficient cash flow to cover its interest expenses. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Embecta Corp EBITDA Coverage Ratio for the year ending September 30, 2022 was 8.52, a -95.18% change year over year.
  • Embecta Corp EBITDA Coverage Ratio for the year ending September 30, 2021 was 176.67.
  • Embecta Corp EBITDA Coverage Ratio for the year ending September 30, 2019 was 269.00.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email